• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素醌白蛋白和血红蛋白加合物作为乳腺癌早期检测的生物标志物。

Albumin and hemoglobin adducts of estrogen quinone as biomarkers for early detection of breast cancer.

机构信息

Department of Environmental Engineering, National Chung Hsing University, South Dist., Taichung, Taiwan, R.O.C.

Department of Dermatology, Changhua Christian Hospital, Changhua, Taiwan, R.O.C.

出版信息

PLoS One. 2018 Sep 17;13(9):e0201241. doi: 10.1371/journal.pone.0201241. eCollection 2018.

DOI:10.1371/journal.pone.0201241
PMID:30222738
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6141067/
Abstract

Cumulative estrogen concentration is an important determinant of the risk of developing breast cancer. Estrogen carcinogenesis is attributed to the combination of receptor-driven mitogenesis and DNA damage induced by quinonoid metabolites of estrogen. The present study was focused on developing an improved breast cancer prediction model using estrogen quinone-protein adduct concentrations. Blood samples from 152 breast cancer patients and 71 healthy women were collected, and albumin (Alb) and hemoglobin (Hb) adducts of estrogen-3,4-quinone and estrogen-2,3-quinone were extracted and evaluated as potential biomarkers of breast cancer. A multilayer perceptron (MLP) was used as the predictor model and the resultant prediction of breast cancer was more accurate than other existing detection methods. A MLP using the logarithm of the concentrations of the estrogen quinone-derived adducts (four input nodes, 10 hidden nodes, and one output node) was used to predict breast cancer risk with accuracy close to 100% and area under curve (AUC) close to one. The AUC value of one showed that both data sets were separable. We conclude that Alb and Hb adducts of estrogen quinones are promising biomarkers for the early detection of breast cancer.

摘要

雌激素浓度累积是乳腺癌发病风险的重要决定因素。雌激素致癌归因于受体驱动的有丝分裂和雌激素醌类代谢物诱导的 DNA 损伤的结合。本研究旨在使用雌激素醌蛋白加合物浓度开发改良的乳腺癌预测模型。采集了 152 名乳腺癌患者和 71 名健康女性的血液样本,并提取和评估了雌激素-3,4-醌和雌激素-2,3-醌的白蛋白 (Alb) 和血红蛋白 (Hb) 加合物作为乳腺癌的潜在生物标志物。多层感知器 (MLP) 用作预测模型,乳腺癌的预测结果比其他现有检测方法更准确。使用雌激素醌衍生加合物浓度的对数的 MLP(四个输入节点、10 个隐藏节点和一个输出节点)来预测乳腺癌风险,准确率接近 100%,曲线下面积 (AUC) 接近 1。AUC 值为 1 表明两个数据集都是可分离的。我们得出结论,雌激素醌的 Alb 和 Hb 加合物是乳腺癌早期检测的有前途的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a17/6141067/385070b4e2d7/pone.0201241.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a17/6141067/dcf8e64b05ad/pone.0201241.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a17/6141067/385070b4e2d7/pone.0201241.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a17/6141067/dcf8e64b05ad/pone.0201241.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a17/6141067/385070b4e2d7/pone.0201241.g002.jpg

相似文献

1
Albumin and hemoglobin adducts of estrogen quinone as biomarkers for early detection of breast cancer.雌激素醌白蛋白和血红蛋白加合物作为乳腺癌早期检测的生物标志物。
PLoS One. 2018 Sep 17;13(9):e0201241. doi: 10.1371/journal.pone.0201241. eCollection 2018.
2
Imbalances in the disposition of estrogen and naphthalene in breast cancer patients: a potential biomarker of breast cancer risk.乳腺癌患者体内雌二醇和萘的处置失衡:乳腺癌风险的潜在生物标志物。
Sci Rep. 2020 Jul 16;10(1):11773. doi: 10.1038/s41598-020-68814-5.
3
Characterization of estrogen quinone-derived protein adducts and their identification in human serum albumin derived from breast cancer patients and healthy controls.鉴定来源于乳腺癌患者和健康对照者的人血清白蛋白中雌激素醌衍生的蛋白加合物及其特征。
Toxicol Lett. 2011 May 10;202(3):244-52. doi: 10.1016/j.toxlet.2011.02.010. Epub 2011 Feb 24.
4
Hemoglobin adducts as biomarkers of estrogen homeostasis: elevation of estrogenquinones as a risk factor for developing breast cancer in Taiwanese women.血红蛋白加合物作为雌激素平衡的生物标志物:雌激素醌的升高是台湾地区女性患乳腺癌的风险因素。
Toxicol Lett. 2014 Mar 21;225(3):386-91. doi: 10.1016/j.toxlet.2014.01.004. Epub 2014 Jan 19.
5
Cumulative body burdens of polycyclic aromatic hydrocarbons associated with estrogen bioactivation in pregnant women: protein adducts as biomarkers of exposure.孕妇体内与雌激素生物活化相关的多环芳烃累积身体负担:蛋白质加合物作为暴露生物标志物
J Environ Sci Health A Tox Hazard Subst Environ Eng. 2014;49(6):634-40. doi: 10.1080/10934529.2014.865416.
6
Profiling of Protein Adducts of Estrogen Quinones in 5-Year Survivors of Breast Cancer Without Recurrence.乳腺癌无复发 5 年幸存者中雌激素醌蛋白加合物的分析。
Cancer Control. 2022 Jan-Dec;29:10732748221084196. doi: 10.1177/10732748221084196.
7
Investigation of the cumulative body burden of estrogen-3,4-quinone in breast cancer patients and controls using albumin adducts as biomarkers.采用白蛋白加合物作为生物标志物研究乳腺癌患者和对照者体内雌酮-3,4-醌的累积量。
Toxicol Lett. 2013 Apr 26;218(3):194-9. doi: 10.1016/j.toxlet.2013.02.004. Epub 2013 Feb 17.
8
Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.儿茶酚雌激素醌作为乳腺癌及其他人类癌症的引发剂:对易感性生物标志物和癌症预防的意义。
Biochim Biophys Acta. 2006 Aug;1766(1):63-78. doi: 10.1016/j.bbcan.2006.03.001. Epub 2006 Apr 19.
9
Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture.雌激素的儿茶酚醌在乳腺癌、前列腺癌及其他人类癌症起始过程中的作用:主题演讲
Ann N Y Acad Sci. 2006 Nov;1089:286-301. doi: 10.1196/annals.1386.042.
10
Evaluation of serum estrogen-DNA adducts as potential biomarkers for breast cancer risk.血清雌激素-DNA 加合物作为乳腺癌风险潜在生物标志物的评估。
J Steroid Biochem Mol Biol. 2012 Oct;132(1-2):73-9. doi: 10.1016/j.jsbmb.2012.02.002. Epub 2012 Feb 24.

引用本文的文献

1
Estrogenized HSA induced high-affinity autoantibodies in breast cancer - Novel biomarker for early detection.雌激素化人血清白蛋白在乳腺癌中诱导产生高亲和力自身抗体——早期检测的新型生物标志物。
Front Oncol. 2024 Nov 27;14:1493320. doi: 10.3389/fonc.2024.1493320. eCollection 2024.
2
Analysis of the Abasic Sites in Breast Cancer Patients With 5 Year Postoperative Treatment Without Recurrence in Taiwan.台湾无复发生存 5 年后的乳腺癌患者碱基切除修复缺陷分析。
Cancer Control. 2024 Jan-Dec;31:10732748241300656. doi: 10.1177/10732748241300656.
3
The Importance of Hypoxia-Related to Hemoglobin Concentration in Breast Cancer.

本文引用的文献

1
Multivariate Feature Selection of Image Descriptors Data for Breast Cancer with Computer-Assisted Diagnosis.用于乳腺癌计算机辅助诊断的图像描述符数据的多变量特征选择
Diagnostics (Basel). 2017 Feb 14;7(1):9. doi: 10.3390/diagnostics7010009.
2
Hemoglobin adducts as biomarkers of estrogen homeostasis: elevation of estrogenquinones as a risk factor for developing breast cancer in Taiwanese women.血红蛋白加合物作为雌激素平衡的生物标志物:雌激素醌的升高是台湾地区女性患乳腺癌的风险因素。
Toxicol Lett. 2014 Mar 21;225(3):386-91. doi: 10.1016/j.toxlet.2014.01.004. Epub 2014 Jan 19.
3
Multiple biomarker panels for early detection of breast cancer in peripheral blood.
缺氧相关血红蛋白浓度在乳腺癌中的重要性。
Cell Biochem Biophys. 2024 Sep;82(3):1893-1906. doi: 10.1007/s12013-024-01386-7. Epub 2024 Jul 3.
4
Imbalances in the disposition of estrogen and naphthalene in breast cancer patients: a potential biomarker of breast cancer risk.乳腺癌患者体内雌二醇和萘的处置失衡:乳腺癌风险的潜在生物标志物。
Sci Rep. 2020 Jul 16;10(1):11773. doi: 10.1038/s41598-020-68814-5.
5
Detection and Characterization of Catechol Quinone-Derived Protein Adducts Using Biomolecular Mass Spectrometry.利用生物分子质谱法检测和表征儿茶酚醌衍生的蛋白质加合物
Front Chem. 2019 Aug 21;7:571. doi: 10.3389/fchem.2019.00571. eCollection 2019.
6
Mass Spectrometry-Based Methodologies for Targeted and Untargeted Identification of Protein Covalent Adducts (Adductomics): Current Status and Challenges.基于质谱的蛋白质共价加合物靶向和非靶向鉴定方法(加合物组学):现状与挑战
High Throughput. 2019 Apr 23;8(2):9. doi: 10.3390/ht8020009.
用于早期检测外周血中乳腺癌的多种生物标志物组合
Biomed Res Int. 2013;2013:781618. doi: 10.1155/2013/781618. Epub 2013 Nov 26.
4
Breast cancer prediction using genome wide single nucleotide polymorphism data.利用全基因组单核苷酸多态性数据预测乳腺癌。
BMC Bioinformatics. 2013;14 Suppl 13(Suppl 13):S3. doi: 10.1186/1471-2105-14-S13-S3. Epub 2013 Oct 1.
5
Support Vector Machine classifier for estrogen receptor positive and negative early-onset breast cancer.支持向量机分类器在雌激素受体阳性和阴性早发性乳腺癌中的应用。
PLoS One. 2013 Jul 19;8(7):e68606. doi: 10.1371/journal.pone.0068606. Print 2013.
6
Investigation of the cumulative body burden of estrogen-3,4-quinone in breast cancer patients and controls using albumin adducts as biomarkers.采用白蛋白加合物作为生物标志物研究乳腺癌患者和对照者体内雌酮-3,4-醌的累积量。
Toxicol Lett. 2013 Apr 26;218(3):194-9. doi: 10.1016/j.toxlet.2013.02.004. Epub 2013 Feb 17.
7
Gene expression profiling of peripheral blood cells for early detection of breast cancer.外周血细胞基因表达谱分析用于乳腺癌的早期检测。
Breast Cancer Res. 2010;12(1):R7. doi: 10.1186/bcr2472. Epub 2010 Jan 15.
8
Unique features of breast cancer in Asian women--breast cancer in Taiwan as an example.亚洲女性乳腺癌的独特特征——以中国台湾为例。
J Steroid Biochem Mol Biol. 2010 Feb 28;118(4-5):300-3. doi: 10.1016/j.jsbmb.2009.12.017. Epub 2010 Jan 4.
9
Do serum biomarkers really measure breast cancer?血清生物标志物真的能检测出乳腺癌吗?
BMC Cancer. 2009 May 28;9:164. doi: 10.1186/1471-2407-9-164.
10
Estrogen metabolism and breast cancer: a risk model.雌激素代谢与乳腺癌:一种风险模型。
Ann N Y Acad Sci. 2009 Feb;1155:68-75. doi: 10.1111/j.1749-6632.2008.03676.x.